June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Paolo Tarantino: The practice-changing results from ASCENT-04 presented by Sara Tolaney
Jun 1, 2025, 17:02

Paolo Tarantino: The practice-changing results from ASCENT-04 presented by Sara Tolaney

Paolo Tarantino, Research Fellow at Dana-Farber Cancer Institute, shared on X:

“Sara Tolaney presents the practice-changing results from ASCENT-04.
Among patients with PDL1+ mTNBC, first-line SG/pembrolizumab improved PFS vs chemo/pembrolizumab (11.2 vs 7.8 months, HR 0.65, p<0.001). Positive OS trend, despite built in crossover.
Huge news for a major unmet need in breast oncology!”

Paolo Tarantino: The practice-changing results from ASCENT-04 presented by Sara Tolaney

You can find more posts featuring Paolo Tarantino on OncoDaily.